Universal Biosensors
Universal Biosensors Inc (UBI) is a global biosensor company and a world leader in electrochemical cell technology. UBI's ambition is to utilize its patented biosensor technology to develop a diverse range of biosensor test strips used in our hand-held portable analyzers; for cost effective, effortless, and accurate detection of analytes of interest, within many industries including human health, animal health, environmental, and agriculture. UBI is a USA Delaware company listed on the Australian Securities Exchange (ASX:UBI) and operates from its head office, manufacturing facility, and research laboratory in Melbourne, Victoria, Australia. In 2021, UBI successfully launched its unique handheld wine analyzer called Sentia™ with an initial test to measure free SO2 , and subsequently in 2022, tests for monitoring malic acid and glucose throughout the wine production process (more tests in the pipeline are due for release in late 2022). In 2022, UBI launched Xprecia Prime™ in the EU and UK, the next-generation blood coagulation analyzer which replaces Xprecia Stride™. Xprecia Prime™ is due for launch in the US in 2023. UBI is due to launch Petrackr™ in late 2022/early 2023, a veterinary blood glucometer to monitor diabetes in cats and dogs. These products will complement UBI's existing Canadian blood testing laboratory Hemostasis Reference Lab (HRL).
Work at Universal Biosensors in HR or recruiting? Claim this page
Headcount trend
Universal Biosensors went from 58 employees in Oct 2024 to 27 in Sep 2026.
Org structure
Headcount by department
Peer reviews
Worked with someone at Universal Biosensors?
Anonymous peer reviews on OffTheRecord
Similar companies
Universal Biosensors FAQ
How many employees does Universal Biosensors have?
Universal Biosensors has about 27 employees, unchanged over the 3 months to Sep 2026.
What is Universal Biosensors's revenue per employee?
Universal Biosensors makes about $214K in revenue per employee, based on $5.77M annual revenue and 27 employees.
Is Universal Biosensors a public company?
Yes. Universal Biosensors is publicly traded under the ticker UBI on ASX.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.